MRNA
Alpha Snapshot
MRNA
Technical: WatchRS rank#1
RS score99.0
Alpha rank#586
Alpha score0.2
Market cap$76.4B
Evidence to review
- Financial comparability: Operating profitability deteriorated; review recent financial results.
- Technical evidence: 50d and 200d breadth have material disagreement; do not collapse them into one risk-on/off read.
- Technical evidence: 20d EMA breadth is early risk-off: 23% above 20d EMA and 71% have two consecutive closes below it.
TechnicalRS Rank
RS score99.0
GroupHealthcare
Group RS83.9
In group99.0
Vs market99.0
Price$193
1M37.2%
3M165.6%
6M279.1%
52w position91.2%
From high-7.8%
Relative volume1.3x
Volume rank91.2%
Close location65.2%
Above 21d: yesAbove 50d: yesAbove 200d: yes50d over 200d: yes
Score Layers
Market8.1Neutral, Mixed
Momentum20.01M 37.2%, 3M 165.6%, 6M 279.1%
Trend15.052w 91.2%, trend 4/4
Demand14.1vol 1.3x, rank 91.2%
Closing strength9.8close 65.2%
Entry quality6.81M 37.2%, from high -7.8%
Drivers
Regime Context8.1
Rs 21d6.0
Rs 63d10.0
Rs 126d4.0
Near 52w High6.8
Trend Structure8.3
Current Demand5.1
Volume Rank 2506.4
AlphaAlpha Rank
TierWeak
Fundamental evidence as of2026-09-30
Coverage100.0%
Rankable Universe586
Category Scores
Growth0.9Weak
Quality2.0Weak
Valuation3.1Weak